Exom Group starts Caravaggio Study, Cloud & Mobile Clinical Trial

Exom Group launched the Caravaggio Study, a Cloud & Mobile Clinical Trial, that will randomize around 1, 200 patients from 160 clinical sites spanning Europe, Israel, and the U.S.

Read the full release here.